Movement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, Life Sciences Sector Rebounds as Multiple Banks Raise Target Prices

Market Focus

Jul 20

On July 20, WuXi AppTec rose 3.14% in regular trading, trading at 158.8 HKD/share, with turnover of HKD 356 million.

On the news front, multiple international investment banks have recently issued bullish upgrades in quick succession, forming a strong consensus. UBS raised WuXi AppTec's target price to 176.5 HKD and named it a sector top pick; Daiwa significantly lifted its target to 190 HKD; Morgan Stanley raised its target to 168 HKD and reiterated the stock as its preferred name, forecasting a 16% adjusted earnings CAGR from 2025 to 2028. The CXO sector is experiencing a broad recovery supported by strong order momentum, with first-quarter new orders posting substantial growth and backlog rising approximately 40.9% year-over-year.

Within the Life Sciences Tools and Services sector, peers rallied in tandem: Pharmaron up 6.29%, JOINN up 6.06%, WuXi XDC up 5.53%, Insilico up 4.95%, and WuXi Biologics up 4.6%, reflecting a pronounced sector-wide linkage effect.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1154404902"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1154404902\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1154404902?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-20 10:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154404902","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, Life Sciences Sector Rebounds as Multiple Banks Raise Target Prices","media":"Market Focus","content":"<p><p>On July 20, WuXi AppTec rose 3.14% in regular trading, trading at 158.8 HKD/share, with turnover of HKD 356 million.</p><p>On the news front, multiple international investment banks have recently issued bullish upgrades in quick succession, forming a strong consensus. UBS raised WuXi AppTec's target price to 176.5 HKD and named it a sector top pick; Daiwa significantly lifted its target to 190 HKD; Morgan Stanley raised its target to 168 HKD and reiterated the stock as its preferred name, forecasting a 16% adjusted earnings CAGR from 2025 to 2028. The CXO sector is experiencing a broad recovery supported by strong order momentum, with first-quarter new orders posting substantial growth and backlog rising approximately 40.9% year-over-year.</p><p>Within the Life Sciences Tools and Services sector, peers rallied in tandem: Pharmaron up 6.29%, JOINN up 6.06%, WuXi XDC up 5.53%, Insilico up 4.95%, and WuXi Biologics up 4.6%, reflecting a pronounced sector-wide linkage effect.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, Life Sciences Sector Rebounds as Multiple Banks Raise Target Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi AppTec Rises 3.14% in Regular Trading, Life Sciences Sector Rebounds as Multiple Banks Raise Target Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-20 10:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 20, WuXi AppTec rose 3.14% in regular trading, trading at 158.8 HKD/share, with turnover of HKD 356 million.</p><p>On the news front, multiple international investment banks have recently issued bullish upgrades in quick succession, forming a strong consensus. UBS raised WuXi AppTec's target price to 176.5 HKD and named it a sector top pick; Daiwa significantly lifted its target to 190 HKD; Morgan Stanley raised its target to 168 HKD and reiterated the stock as its preferred name, forecasting a 16% adjusted earnings CAGR from 2025 to 2028. The CXO sector is experiencing a broad recovery supported by strong order momentum, with first-quarter new orders posting substantial growth and backlog rising approximately 40.9% year-over-year.</p><p>Within the Life Sciences Tools and Services sector, peers rallied in tandem: Pharmaron up 6.29%, JOINN up 6.06%, WuXi XDC up 5.53%, Insilico up 4.95%, and WuXi Biologics up 4.6%, reflecting a pronounced sector-wide linkage effect.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02359","symbol_name":"药明康德","start_time":0,"source_url":"","article_id":"1154404902","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154404902","pubTimestamp":1784513205,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 20, WuXi AppTec rose 3.14% in regular trading, trading at 158.8 HKD/share, with turnover of HKD 356 million.On the news front, multiple international investment banks have recently issued...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02359":"药明康德"},"translate_title":"走势提醒|药明康德常规交易上涨3.14%，多家银行上调目标价，生命科学板块反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1},"content_text":"On July 20, WuXi AppTec rose 3.14% in regular trading, trading at 158.8 HKD/share, with turnover of HKD 356 million.On the news front, multiple international investment banks have recently issued bullish upgrades in quick succession, forming a strong consensus. UBS raised WuXi AppTec's target price to 176.5 HKD and named it a sector top pick; Daiwa significantly lifted its target to 190 HKD; Morgan Stanley raised its target to 168 HKD and reiterated the stock as its preferred name, forecasting a 16% adjusted earnings CAGR from 2025 to 2028. The CXO sector is experiencing a broad recovery supported by strong order momentum, with first-quarter new orders posting substantial growth and backlog rising approximately 40.9% year-over-year.Within the Life Sciences Tools and Services sector, peers rallied in tandem: Pharmaron up 6.29%, JOINN up 6.06%, WuXi XDC up 5.53%, Insilico up 4.95%, and WuXi Biologics up 4.6%, reflecting a pronounced sector-wide linkage effect.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}